Figure legends
Figure 1. Flowchart for
selection of the study patients
Figure 2. The cumulative incidence rate of arterial
thromboembolic event (A), ischemic stroke (B), extracranial arterial
thromboembolic events (C), cardiovascular death (D) and all-cause
mortality (E) after propensity score matching comparing patients with
venous thromboembolism and those with atrial fibrillation.
Figure 3. The cumulative incidence rate of arterial
thromboembolic event (A), ischemic stroke (B), extracranial arterial
thromboembolic events (C), cardiovascular death (D) and all-cause
mortality (E) after propensity score matching comparing patients with
deep vein thrombosis alone and those with atrial fibrillation.
Figure 4. The cumulative incidence rate of arterial
thromboembolic event (A), ischemic stroke (B), extracranial arterial
thromboembolic events (C), cardiovascular death (D) and all-cause
mortality (E) after propensity score matching comparing patients with
pulmonary embolism alone and those with atrial fibrillation.
Figure 5: The cumulative incidence rate of arterial
thromboembolic event (A), ischemic stroke (B), extracranial arterial
thromboembolic events (C), cardiovascular death (D) and all-cause
mortality (E) after propensity score matching comparing patients with
pulmonary embolism alone and those with deep vein thrombosis alone.
Figure 6. The incidence of arterial thromboembolic events and
mortality between VTE and AF cohorts. The incidence of ischemic stroke
and myocardial infarction were lower in VTE cohort than AF cohort but
ECATE, particularly in low extremity, was lower in AF cohort than VTE
cohort. In terms of mortality, CV death was lower in VTE cohorts than AF
cohort while all-cause mortality and non-CV death were lower in AF
cohort than VTE cohort. Abbreviation: AF: atrial fibrillation, CV:
cardiovascular; ECATE: extracranial arterial thromboembolic event; VTE:
venous thromboembolism.